Company / PP&E (Net)
NEUROONE MEDICAL TECHNOLOGIES Corp PP&E (Net) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$259.2K
FY2025
5-year range
$166.0K / $525.8K
FY2021-FY2025
Trend
-37.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $525,753 to $259,222 over the past 2 years.
Based on SEC 10-K filings.
$259,222 in FY2025 with a 3-year CAGR of -9.8%.
Declined from $525,753 to $259,222 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -9.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -9.8%, indicating a declining trend.
- In FY2025, pp&e (net) decreased 37.8% year-over-year.
- Peak pp&e (net) was recorded in FY2023.
- Lowest pp&e (net) in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $259.2K | -37.8% |
| FY2024 | $416.8K | -20.7% |
| FY2023 | $525.8K | +48.7% |
| FY2022 | $353.6K | +113.0% |
| FY2021 | $166.0K | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026